Consilium MedicumConsilium MedicumConsilium MedicumConsilium Medicum2075-17532542-2170Consilium Medicum94758ArticlesСтатьиScientific ReportDiagnosis and treatment of primary adrenal insufficiency in adult: a Russian Association of Endocrinology Clinical Practice Guideline (project)Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечению первичной надпочечниковой недостаточности у взрослых пациентов (проект)MelnichenkoG. AМельниченкоГ. А

акад. ран, д-р мед. наук, проф., дир. ФГБУ ЭНЦ

TroshinaE. AТрошинаЕ. А

д-р мед. наук, проф., зав. отд-нием терапевтической эндокринологии ФГБУ ЭНЦ

YukinaM. YuЮкинаМ. Ю

канд. мед. наук, ст. науч. сотр. отд. терапевтической эндокринологии, ФГБУ ЭНЦ

PlatonovaN. MПлатоноваН. М

д-р мед. наук, гл. науч. сотр. отд-ния терапевтической эндокринологии ФГБУ ЭНЦ

doc-platonova@inbox.ruBeltsevichaD. GБельцевичД. Г

д-р мед. наук, гл. науч. сотр. отд. хирургии ФГБУ ЭНЦ

Endocrinology research center of the Ministry of Health of the Russian FederationФГБУ «Эндокринологический научный центр» Минздрава России15042017194VOL 19, NO4 (2017)ТОМ 19, №4 (2017)81928122021Copyright ©; 2017, Consilium MedicumCopyright ©; 2017, ООО "Консилиум Медикум"2017Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://consilium.orscience.ru/2075-1753/article/view/94758

In the project of clinical recommendations Russian Association of Endocrinology focused on diagnosis and differential diagnosis of primary adrenal insufficiency with special reference to diagnostic steps, major pharmacological tests, instrumental studies. Strategies of management of patients with this pathology are described.

В статье представлен проект клинических рекомендаций Российской ассоциации эндокринологов по диагностике и лечению первичной надпочечниковой недостаточности, в котором приведен современный алгоритм обследования пациентов с первичной надпочечниковой недостаточностью, рассмотрены основные принципы лабораторной, инструментальной диагностики и патогенетические подходы к лечению.

Addison's diseaseprimary adrenal insufficiencyadrenal insufficiencyglucocorticoid replacement therapyболезнь Аддисонапервичная надпочечниковая недостаточностьнадпочечниковая недостаточностьзаместительная терапия глюкокортикоидамиHahner S, Allolio B. Therapeutic management of adrenal insufficiency. Best Pract Res Clin Endocrinol Metab 2009; 23: 167-79.Meyer G, Hackemann A, Penna-Martinez M, Badenhoop K. What affects the quality of life in autoimmune Addison’s disease? Horm Metab Res 2013; 45: 92-5.Chakera A.J, Vaidya B. Addison disease in adults: diagnosis and management. Am J Med 2010; 123: 409-13.Meyer G, Neumann K, Badenhoop K, Linder R. Increasing prevalence of Addison’s disease in German females: health insurance data 2008-2012. Eur J Endocrinol 2014; 170: 367-73.Bornstein S.R. Predisposing factors for adrenal insufficiency. N Engl J Med 2009; 360: 2328-39.Мельниченко Г.А. и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике и лечебно - профилактическим мероприятиям при врожденной дисфункции коры надпочечников у пациентов во взрослом возрасте // Consilium Medicum. 2016; 18 (4): 8-19.Kazlauskaite R, Evans A.T, Villabona C.V et al. Corticotropin tests for hypothalamic - pituitary - adrenal insufficiency: a metaanalysis. J Clin Endocrinol Metab 2008; 93: 4245-53.Lee M.K, Vasikaran S, Doery J.C et al. Cortisol: ACTH ratio to test for primary hypoadrenalism: a pilot study. Postgrad Med J 2013; 89: 617-20.Cho H.Y, Kim J.H, Kim S.W et al. Different cut - off values of the insulin tolerance test, the high - dose short Synacthen test (250 mg) and the low - dose short Synacthen test (1 mg) in assessing central adrenal insufficiency. Clin Endocrinol (Oxf) 2014; 81: 77-84.Bornstein S.R, Allolio B, Arlt W et al. Diagnosis and Treatment of Primary Adrenal Insufficiency: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2016; 101 (2): 364-89.Gundgurthi A, Garg M.K, Dutta M.K, Pakhetra R. Intramuscular ACTH stimulation test for assessment of adrenal function. J Assoc Physicians India 2013; 61: 320-4.Gagliardi L, Ho J.T, Torpy D.J. Corticosteroid - binding globulin: the clinical significance of altered levels and heritable mutations. Mol Cell Endocrinol 2010; 316: 24-34.Lebbe M, Arlt W. What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy? Clin Endocrinol (Oxf) 2013; 78: 497-502.Speiser P.W, Azziz R, Baskin L.S et al. Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2010; 95: 4133-60.El-Farhan N, Pickett A, Ducroq D et al. Method - specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography - mass spectrometry and five automated immunoassays. Clin Endocrinol (Oxf) 2013; 78: 673-80.Дедов И.И., Мельниченко Г.А., Фадеев В.В. Эндокринология. 3-е изд., перераб. и доп. М.: Литтерра, 2015.Baker P.R, Baschal E.E, Fain P.R et al. Haplotype analysis discriminates genetic risk for DR3-associated endocrine autoimmunity and helps define extreme risk for Addison’s disease. J Clin Endocrinol Metab 2010; 95: E263-E270.Coco G, Dal Pra C, Presotto F et al. Estimated risk for developing autoimmune Addison’s disease in patients with adrenal cortex autoantibodies. J Clin Endocrinol Metab 2006; 91: 1637-45.Meager A, Visvalingam K, Peterson P et al. Anti - interferon autoantibodies in autoimmune polyendocrinopathy syndrome type 1. PLoS Med 2006; 3: e289.Horn M.A, Erichsen M.M, Wolff A.S et al. Screening for X-linked adrenoleukodystrophy among adult men with Addison’s disease. Clin Endocrinol (Oxf) 2013; 79: 316-20.Ekman B, Bachrach-Lindström M, Lindström T et al. A randomized, double - blind, crossover study comparing two - and four - dose hydrocortisone regimen with regard to quality of life, cortisol and ACTH profiles in patients with primary adrenal insufficiency. Clin Endocrinol (Oxf) 2012; 77: 18-25.Forss M, Batcheller G, Skrtic S, Johannsson G. Current practice of glucocorticoid replacement therapy and patient - perceived health outcomes in adrenal insufficiency - a worldwide patient survey. BMC Endocr Disord 2012; 12: 8.Johannsson G, Nilsson A.G, Bergthorsdottir R et al. Improved cortisol exposure - time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual - release formulation. J Clin Endocrinol Metab 2012; 97: 473-81.Miller W.L, Auchus R.J. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32: 81-151.Methlie P, Husebye E.E, Hustad S et al. Grapefruit juice and licorice increase cortisol availability in patients with Addison’s disease. Eur J Endocrinol 2011; 165: 761-9.Ross I.L, Bergthorsdottir R, Levitt N et al. Cardiovascular risk factors in patients with Addison’s disease: a comparative study of South African and Swedish patients. PLoS One 2014; 9: e90768.Inder W.J, Meyer C, Hunt P.J. Management of hypertension and heart failure in patients with Addison’s disease. Clin Endocrinol (Oxf) 2015; 82: 789-92.Bancos I, Hahner S, Tomlinson J, Arlt W. Diagnosis and management of adrenal insufficiency. Lancet Diabetes Endocrinol 2015; 3: 216-26.Allolio B. Extensive expertise in endocrinology: adrenal crisis. Eur J Endocrinol 2015; 172: R115-R124.Hahner S, Spinnler C, Fassnacht M et al. High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 2015; 100: 407-16.Reisch N, Willige M, Kohn D et al. Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur J Endocrinol 2012; 167: 35-42.Chortis V, Taylor A.E, Schneider P et al. Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5a - reductase, explaining the need for personalized glucocorticoid and androgen replacement. J Clin Endocrinol Metab 2013; 98: 161-71.Quinkler M, Hahner S. What is the best long - term management strategy for patients with primary adrenal insufficiency? Clin Endocrinol (Oxf) 2012; 76: 21-5.Boonen E, Vervenne H, Meersseman P et al. Reduced cortisol metabolism during critical illness. N Engl J Med 2013; 368: 1477-88.Hahner S, Burger-Stritt S, Allolio B. Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. Eur J Endocrinol 2013; 169: 147-54.Hahner S, Hemmelmann N, Quinkler M et al. Timelines in the management of adrenal crisis - targets, limits and reality. Clin Endocrinol (Oxf) 2015; 82: 497-502.Repping-Wuts H.J, Stikkelbroeck N.M, Noordzij A et al. A glucocorticoid education group meeting: an effective strategy for improving self - management to prevent adrenal crisis. Eur J Endocrinol 2013; 169: 17-22.Quinkler M, Dahlqvist P, Husebye E.S, Kämpe O. A European Emergency Card for adrenal insufficiency can save lives. Eur J Intern Med 2015; 26: 75-6.Reato G, Morlin L, Chen S et al. Premature ovarian failure in patients with autoimmune Addison’s disease: clinical, genetic, and immunological evaluation. J Clin Endocrinol Metab 2011; 96: E1255-E1261.Falorni A, Brozzetti A, Aglietti M.C et al. Progressive decline of residual follicle pool after clinical diagnosis of autoimmune ovarian insufficiency. Clin Endocrinol (Oxf) 2012; 77: 453-8.Charmandari E, Nicolaides N.C, Chrousos G.P. Adrenal insufficiency. Lancet 2014; 383: 2152-67.Christiansen J.J, Bruun J.M, Christiansen J.S et al. Long - term DHEA substitution in female adrenocortical failure, body composition, muscle function, and bone metabolism: a randomized trial. Eur J Endocrinol 2011; 165: 293-300.Keevil B.G. Novel liquid chromatography tandem mass spectrometry (LC-MS/MS) methods for measuring steroids. Best Pract Res Clin Endocrinol Metab 2013; 27: 663-74.Mallappa A, Sinaii N, Kumar P et al. A phase 2 study of Chronocort, a modified - release formulation of hydrocortisone. J Clin Endocrinol Metab 2015; 100: 1137-45.Oksnes M, Björnsdottir S, Isaksson M et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison’s disease: a randomized clinical trial. J Clin Endocrinol Metab 2014; 99: 1665-74.Gagliardi L, Nenke M.A, Thynne T.R et al. Continuous subcutaneous hydrocortisone infusion therapy in Addison’s disease: a randomized, placebo - controlled clinical trial. J Clin Endocrinol Metab 2014; 99: 4149-57.Russell G.M, Durant C, Ataya A et al. Subcutaneous pulsatile glucocorticoid replacement therapy. Clin Endocrinol (Oxf) 2014; 81: 289-93.Gan E.H, Mc Arthur K, Mitchell A.L et al. Residual adrenal function in autoimmune Addison’s disease: improvement after tetracosactide (ACTH1-24) treatment. J Clin Endocrinol Metab 2014; 99: 111-8.Husebye E.S et al. Consensus statement on the diagnosis, treatment and follow - up of patients with primary adrenal insufficiency. J Intern Med 2014; 275: 104-15.